← Leaderboards
Alon Goren
University Of California, San Diego
$4,518,569
Attributed
$8,857,148
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,857,148 · 5
By mechanism
R01$7,235,064 · 2
R21$864,927 · 2
R56$757,157 · 1
Top collaborators
- Melissa Gymrek9 shared
- Alysson R. Muotri4 shared
- Alexis C. Komor1 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Lee A. Niswander$14,703,716
- Alysson R. Muotri$33,814,580
- Shujuan Chen$1,213,224
- Melissa Gymrek$12,234,686
- Tsung-Ting Kuo$3,736,682
Others in their field
Other Emerging Leaders on “Genomics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- Scott Topper · Broad Institute, Inc.$153,234,573
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,892,657
- Leonard Freedmand · Leidos Biomedical Research, Inc.$96,686,407
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Scott Andrew Sutherland · Vignet, Inc.$37,105,117
Research focus
GenomicsGenesGenetic VariantGenome EditingGenomeMutationTraitComplexGenetic VariationCatalogsData SetAutomobile DrivingFailureMolecular BiologyStructureAffectLinkDesignPhenotypeVariantGene ExpressionMolecular PhenotypeExhibitsGenotype
Grant awards (15)
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$781,258
R01 · FY2025 · MH
Systematic characterization of tandem repeat variants contributing to complex traits$634,178
R01 · FY2025 · HG
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$784,231
R01 · FY2024 · MH
A framework for interpreting global effects of genetic variants contributing to disease risk$757,157
R56 · FY2024 · HG · contact PI
Systematic characterization of tandem repeat variants contributing to complex traits$638,253
R01 · FY2024 · HG
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$787,147
R01 · FY2023 · MH
Systematic characterization of tandem repeat variants contributing to complex traits$705,000
R01 · FY2023 · HG
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism$789,998
R01 · FY2022 · MH
Systematic characterization of tandem repeat variants contributing to complex traits$705,000
R01 · FY2022 · HG
Systematic characterization of tandem repeat variants contributing to complex traits$705,000
R01 · FY2021 · HG
Systematic characterization of tandem repeat variants contributing to complex traits$704,999
R01 · FY2020 · HG
Interrogating regulatory variants by multiplexed genome editing$236,250
R21 · FY2019 · HG
Development of a novel method to chart genomic localization of protein complexes in vivo$236,125
R21 · FY2019 · HG · contact PI
Interrogating regulatory variants by multiplexed genome editing$196,302
R21 · FY2018 · HG
Development of a novel method to chart genomic localization of protein complexes in vivo$196,250
R21 · FY2018 · HG · contact PI